Real-time enrollment status for this drug-drug interaction clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 7:07 AM UTC
| NCT Number | NCT07652723 |
| Recruiting Status | Recruiting |
| Condition | Drug-drug Interaction |
| Phase | PHASE1 |
| Target Enrollment | 16 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Bayer |
| Last Updated on CT.gov | August 26, 2026 (1 week ago) |
As of September 2, 2026: Clinical trial NCT07652723 is currently recruiting participants. This phase1 study for drug-drug interaction is actively seeking new participants at 1 location across the United States. The study is sponsored by Bayer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07652723 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07652723 was last updated 1 week ago (August 26, 2026). HelloStudys verifies this status automatically.